Inactivation mechanisms and growth suppressive effects of p16INK4a in Asian esophageal squamous carcinoma cell lines

Cancer Letters

Volumn 208, Issue 2, 2004, Pages 207-213

  Kwong, Fung Mei ^a   Tang, Johnny Cheuk On ^b,c   Srivastava, Gopesh ^c   Lung, Maria Li ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Esophageal squamous cell carcinoma; p16INK4a; Promoter hypermethylation; Transfection

Indexed keywords

MUTANT PROTEIN;

ARTICLE; ASIAN; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL LINE; COLONY FORMATION; DNA SEQUENCE; ESOPHAGUS CARCINOMA; EXON; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE DELETION; GENE INACTIVATION; GENE SILENCING; GENETIC TRANSCRIPTION; HOMOZYGOSITY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENES, P16; HUMANS; LOSS OF HETEROZYGOSITY; POLYMERASE CHAIN REACTION;

EID: 2442567836     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.017     Document Type: Article

References (35)

1. Ortega S., Malumbres M., Barbacid M. Cyclin D-dependent kinase, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:2002;73-87
2. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
3. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MST1 in human cancers. Nat. Med. 1:1995;686-692
4. Kamb A. Cell-cycle regulators and cancer. Trends Genet. 11:1995;136-140
5. INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis. 20:1999;77-84
6. Maesawa C., Tamura G., Nishizuka S., Ogasawara S., Ishida K., Terashima M., et al. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res. 56:1996;3875-3878
7. Tanaka H., Shimada Y., Imamura M., Shibagaki I., Ishizaki K. Multiple types of aberrations in the p16(INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int. J. Cancer. 70:1997;437-442
8. Mori T., Miura K., Aoki T., Nishihira T., Mori S., Nakamura Y. Frequent somatic mutation of the MST1/CDK4I (multiple tumor-suppressor/cyclin-dependent kinase-4 inhibitor) gene in esophageal squamous-cell carcinoma. Cancer Res. 54:1994;3396-3397
9. Zhou X., Tarmin L., Yin L., Jiang H.Y., Suzuki H., Rhyu M.G., et al. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene. 9:1994;3737-3741
10. Igaki H., Sasaki H., Tachimori Y., Kato H., Watanabe H., Kimura T., et al. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res. 55:1995;3421-3423
11. Hu Y.C., Lam K.Y., Law S.Y., Wan T.S.K., Ma E.S.K., Kwong Y.L., et al. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet. Cytogen. 135:2002;120-127
12. Tang J.C.O., Wan T.S.K., Wong N., Pang E., Lam K.Y., Law S.Y., et al. Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet. Cytogen. 124:2001;36-41
13. Takahashi K., Kanazama H., Chan C.T., Hosono T., Takahara M., Sato K. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T-T and T-Tn) established from the oral tumor. Jpn. J. Oral Maxillofac. Surg. 36:1990;307-316
14. Strauss M.W. Preparation of genomic DNA from mammalian tissue. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Strunl K. Current protocols in molecular biology volume 1. 1989;2.2.1-2.2.3 Wiley, New York
15. Herman J.G., Graff J.R., Myöhänen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826
16. ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats. Cancer Res. 60:2000;4589-4595
17. Liggett W.H. Jr., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16:1998;1197-1206
18. Xing E.P., Nie Y., Song Y., Yang G.Y., Cai Y.C., Wang L.D., Yang C.S. Mechanisms of inactivation of p14ARF, p15INK4a, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin. Cancer Res. 5:1999;1231-1240
19. Chan W.C., Tang C.M.C., Lau K.W., Lung M.L. p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong. Cancer Lett. 115:1997;201-206
20. Kitahara K., Yasui W., Yokozaki H., Semba S., Hamamoto T., Hisatsugu T., Tahara E. Expression of cyclin D1, CDK4, p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J. Expt. Ther. Onc. 1:1996;7-12
21. Montesano R., Hollstein M., Hainau P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer. 69:1996;225-235
22. Lu G., Chen X., Cao W. Multiple tumor suppressor 1/p16 gene alterations in human esophageal squamous-cell carcinoma: clinical significance and regional difference. Zhonghua Zhong Liu Za Zhi. 21:1999;359-362
23. Yang L., Tang C.M.C., Lau K.W., Lung M.L. Frequent loss of heterozygosity on chromosome 9 in Chinese esophageal squamous cell carcinomas. Cancer Lett. 203:2003;71-77
24. Smeds J., Berggren P., Ma X., Xu Z., Hemminki K., Kumar R. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16INK4a and p14ARF) and p53 genes are major targets for inactivation. Carcinogenesis. 23:2002;645-655
25. Nie Y.B., Liao J., Zhao X., Song Y., Yang G.Y., Wang L.D., Yang C.S. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis. 23:2002;1713-1720
26. INK4a and p53 genes into the K562 cell line inhibits cell proliferation. Haematologica. 87:2002;136-142
27. Simon M., Köster G., Menon A.G., Schramm J. Functional evidence for a role of combined CDKN2A (p16-p14ARF)/CDKN2B (p15) gene inactivation in malignant gliomas. Acta Neuropathol. 98:1999;444-452
28. Park Y.B., Park M.J., Kimura K., Shimizu K., Lee S.H., Yokota J. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 133:2002;105-111
29. Cheng Y., Stanbridge E.J., Kong H., Bengtsson U., Lerman M.I., Lung M.L. A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chrom. Cancer. 28:2000;82-91
30. Zhou X., Suzuki H., Lei J., Cole K., Yin J., Suzuki Y., et al. Growth suppression of esophageal cancer cells by p16INK4 and p15INK4B in vitro. Cancer J. Sci. Am. 2:1996;221-224
31. Spillare E.A., Okamoto A., Hagiwara K., Demetrick D.J., Serrano M., Beach D., Harris C.C. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4. Mol. Carcinogen. 16:1996;53-60
32. Uhrbom L., Nistér M., Westermark B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene. 15:1997;505-514
33. England N.L., Cuthbert A.P., Trott D.A., Jezzard S., Nobori T., Carson D.A., Newbold R.F. Identification of human tumour suppressor genes by monochromosome transfer: rapid growth-arrest response mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis. 17:1996;1567-1575
34. Wu Q., Possati L., Montesi M., Gualandi F., Rimessi P., Morelli C., et al. Growth arrest and suppression of tumorigenicity of bladder carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9. Int. J. Cancer. 65:1996;840-846
35. Wang G.L., Lo K.W., Tsang K.S., Chung N.Y.F., Tsang Y.S., Cheung S.T., et al. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma. Br. J. Cancer. 81:1999;1122-1126